Intl. Biotechnology Trust PLC
27 July 2000
International Biotechnology Trust plc
Following the Extraordinary General Meeting held on 7th July 2000, discussions
have been held with shareholders representing more than 50 per cent of the
outstanding share capital of the Company, including Millennium Partners LP.
In light of these discussions, the Directors are now formulating detailed
proposals which they intend to put to shareholders for their approval before
the end of October 2000.
These proposals will be designed to enable shareholders who wish to retain a
continuing investment in the international biotechnology sector to do so
through a vehicle whose initial net asset value will comprise not less than 50
per cent of the Company's assets. Within this parameter, arrangements will be
made for shareholders who wish to realise all or part of their investment to
do so through the realisation of assets attributable to their interest in the
Company.
The proposals will seek to maximise shareholder value and achieve a balance
between those shareholders electing to realise their interest and those who
wish to continue their investment in biotechnology.
The Board will be inviting potential investment managers, including Rothschild
Asset Management, to submit proposals for the investment management contract.
Enquiries:
Peter Moorhouse/Melville Trimble - Merrill Lynch 020 7772 1000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.